These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7437314)
1. Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses. Viglioglia PA Br J Dermatol; 1980 Nov; 103(5):483-7. PubMed ID: 7437314 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)]. Pehamberger H; Esca SA; Holubar K Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336 [TBL] [Abstract][Full Text] [Related]
3. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason. Greig DE; Wishart J; Hodge JL N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease. Burge SM; Wilkinson JD; Miller AJ; Ryan TJ Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178 [TBL] [Abstract][Full Text] [Related]
5. Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason). Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H Dermatologica; 1981; 163(2):164-8. PubMed ID: 7286356 [TBL] [Abstract][Full Text] [Related]
6. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis]. Rüst O; Tufli T Schweiz Med Wochenschr; 1979 Dec; 109(48):1921-5. PubMed ID: 161414 [TBL] [Abstract][Full Text] [Related]
7. Severe disorders of keratinization: effects of treatment with Tigason (etretinate). Marks R; Finlay AY; Holt PJ Br J Dermatol; 1981 Jun; 104(6):667-73. PubMed ID: 7248177 [TBL] [Abstract][Full Text] [Related]
8. [Oral treatment of various dermatosis with the aromatic derivative of retinoic acid Ro 10-9359]. Cordero AA; Allevato MA; Barclay CA; Traballi CA Med Cutan Ibero Lat Am; 1978; 6(5-6):243-51. PubMed ID: 398925 [TBL] [Abstract][Full Text] [Related]
9. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients. Mahrle G; Meyer-Hamme S; Ippen H Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226 [TBL] [Abstract][Full Text] [Related]
10. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal. Findlay GH S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876 [TBL] [Abstract][Full Text] [Related]
11. Effects of etretinate (Ro 10-9359) on Darier's Disease. Löwhagen GB; Michaëlsson G; Mobacken H; Pettersson U; Vahlquist A Dermatologica; 1982 Aug; 165(2):123-30. PubMed ID: 7141063 [TBL] [Abstract][Full Text] [Related]
12. [Etretinat (Tigason). A vitamin A acid derivative for peroral treatment of hyperkeratotic dermatoses]. Foged EK; Laurberg G; Schmidt H Ugeskr Laeger; 1983 Jun; 145(23):1797-9. PubMed ID: 6879814 [No Abstract] [Full Text] [Related]